Sustained effects of single doses of classical psychedelics in humans

Research output: Contribution to journalReviewResearchpeer-review

Standard

Sustained effects of single doses of classical psychedelics in humans. / Knudsen, Gitte M.

In: Neuropsychopharmacology, Vol. 48, No. 1, 2023, p. 145-150.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Knudsen, GM 2023, 'Sustained effects of single doses of classical psychedelics in humans', Neuropsychopharmacology, vol. 48, no. 1, pp. 145-150. https://doi.org/10.1038/s41386-022-01361-x

APA

Knudsen, G. M. (2023). Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology, 48(1), 145-150. https://doi.org/10.1038/s41386-022-01361-x

Vancouver

Knudsen GM. Sustained effects of single doses of classical psychedelics in humans. Neuropsychopharmacology. 2023;48(1):145-150. https://doi.org/10.1038/s41386-022-01361-x

Author

Knudsen, Gitte M. / Sustained effects of single doses of classical psychedelics in humans. In: Neuropsychopharmacology. 2023 ; Vol. 48, No. 1. pp. 145-150.

Bibtex

@article{3e48264ae77244f4bcfd9554947dcb81,
title = "Sustained effects of single doses of classical psychedelics in humans",
abstract = "The serotonergic classical psychedelics include compounds that primarily activate the brain{\textquoteright}s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy people and in those with neuropsychiatric disorders. In particular psilocybin, the psychoactive constituent in “magic mushrooms”, has shown great potential for treatment of anxiety and depression. A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects. This includes effects on personality, e.g., higher openness, and amelioration of depressive symptoms. This review focuses on these stunning effects and summarizes our current knowledge on which behavioral, biochemical, neuroimaging, and electrophysiological data support that the intriguing effects of psychedelics on the human brain and mind are based on neural plasticity. The review also points to so far understudied areas and suggests research questions to be addressed in future studies which potentially can help to understand the intriguing long-term effects after intake of a single (or a few) psychedelic doses.",
author = "Knudsen, {Gitte M.}",
note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",
year = "2023",
doi = "10.1038/s41386-022-01361-x",
language = "English",
volume = "48",
pages = "145--150",
journal = "Neuropsychopharmacology",
issn = "0893-133X",
publisher = "nature publishing group",
number = "1",

}

RIS

TY - JOUR

T1 - Sustained effects of single doses of classical psychedelics in humans

AU - Knudsen, Gitte M.

N1 - Publisher Copyright: © 2022, The Author(s).

PY - 2023

Y1 - 2023

N2 - The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy people and in those with neuropsychiatric disorders. In particular psilocybin, the psychoactive constituent in “magic mushrooms”, has shown great potential for treatment of anxiety and depression. A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects. This includes effects on personality, e.g., higher openness, and amelioration of depressive symptoms. This review focuses on these stunning effects and summarizes our current knowledge on which behavioral, biochemical, neuroimaging, and electrophysiological data support that the intriguing effects of psychedelics on the human brain and mind are based on neural plasticity. The review also points to so far understudied areas and suggests research questions to be addressed in future studies which potentially can help to understand the intriguing long-term effects after intake of a single (or a few) psychedelic doses.

AB - The serotonergic classical psychedelics include compounds that primarily activate the brain’s serotonin 2 A receptor (5-HT2AR), such as LSD, psilocybin, and DMT (ayahuasca). The acute effects of these compounds are well-known as are their ability to increase the emotional state both in healthy people and in those with neuropsychiatric disorders. In particular psilocybin, the psychoactive constituent in “magic mushrooms”, has shown great potential for treatment of anxiety and depression. A unique and compelling feature of psychedelics is that intake of just a single psychedelic dose is associated with long-lasting effects. This includes effects on personality, e.g., higher openness, and amelioration of depressive symptoms. This review focuses on these stunning effects and summarizes our current knowledge on which behavioral, biochemical, neuroimaging, and electrophysiological data support that the intriguing effects of psychedelics on the human brain and mind are based on neural plasticity. The review also points to so far understudied areas and suggests research questions to be addressed in future studies which potentially can help to understand the intriguing long-term effects after intake of a single (or a few) psychedelic doses.

UR - http://www.scopus.com/inward/record.url?scp=85132327113&partnerID=8YFLogxK

U2 - 10.1038/s41386-022-01361-x

DO - 10.1038/s41386-022-01361-x

M3 - Review

C2 - 35729252

AN - SCOPUS:85132327113

VL - 48

SP - 145

EP - 150

JO - Neuropsychopharmacology

JF - Neuropsychopharmacology

SN - 0893-133X

IS - 1

ER -

ID: 330476100